6HUP image
Entry Detail
PDB ID:
6HUP
EMDB ID:
Title:
CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with diazepam (Valium), GABA and megabody Mb38.
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-10-09
Release Date:
2019-01-02
Method Details:
Experimental Method:
Resolution:
3.58 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Gamma-aminobutyric acid receptor subunit alpha-1,Gamma-aminobutyric acid receptor subunit alpha-1
Chain IDs:A, D
Chain Length:464
Number of Molecules:2
Biological Source:Bos taurus, Homo sapiens
Polymer Type:polypeptide(L)
Description:Gamma-aminobutyric acid receptor subunit beta-3
Chain IDs:B, E
Chain Length:473
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Gamma-aminobutyric acid receptor subunit gamma-2
Chain IDs:C
Chain Length:495
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Megabody Mb38
Chain IDs:F (auth: G)
Chain Length:539
Number of Molecules:1
Biological Source:Lama glama
Primary Citation
GABAAreceptor signalling mechanisms revealed by structural pharmacology.
Nature 565 454 459 (2019)
PMID: 30602790 DOI: 10.1038/s41586-018-0832-5

Abstact

Type-A γ-aminobutyric (GABAA) receptors are ligand-gated chloride channels with a very rich pharmacology. Some of their modulators, including benzodiazepines and general anaesthetics, are among the most successful drugs in clinical use and are common substances of abuse. Without reliable structural data, the mechanistic basis for the pharmacological modulation of GABAA receptors remains largely unknown. Here we report several high-resolution cryo-electron microscopy structures in which the full-length human α1β3γ2L GABAA receptor in lipid nanodiscs is bound to the channel-blocker picrotoxin, the competitive antagonist bicuculline, the agonist GABA (γ-aminobutyric acid), and the classical benzodiazepines alprazolam and diazepam. We describe the binding modes and mechanistic effects of these ligands, the closed and desensitized states of the GABAA receptor gating cycle, and the basis for allosteric coupling between the extracellular, agonist-binding region and the transmembrane, pore-forming region. This work provides a structural framework in which to integrate previous physiology and pharmacology research and a rational basis for the development of GABAA receptor modulators.

Legend

Protein

Chemical

Disease

Primary Citation of related structures